Business Description
TRACON Pharmaceuticals Inc
NAICS : 325411
SIC : 2836
ISIN : US89237H1005
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 33.44 | |||||
Equity-to-Asset | -0.19 | |||||
Debt-to-Equity | -0.13 | |||||
Debt-to-EBITDA | 0.03 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -32.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 72.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.8 | |||||
Quick Ratio | 0.8 | |||||
Cash Ratio | 0.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -41.9 | |||||
Shareholder Yield % | 110.72 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -39.5 | |||||
Net Margin % | 14.39 | |||||
FCF Margin % | -4.39 | |||||
ROE % | Neg. Equity | |||||
ROA % | 17.7 | |||||
ROIC % | -229.48 | |||||
ROC (Joel Greenblatt) % | 3535.26 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.15 | |||||
EV-to-EBIT | -0.64 | |||||
EV-to-EBITDA | -0.63 | |||||
EV-to-Revenue | -0.41 | |||||
EV-to-FCF | -0.81 | |||||
Earnings Yield (Greenblatt) % | -156.25 | |||||
FCF Yield % | 183.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TRACON Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8.307 | ||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 3.58 - 3.58 | ||
Shares Outstanding (Mil) | 19.43 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TRACON Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TRACON Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
TRACON Pharmaceuticals Inc Frequently Asked Questions
What is TRACON Pharmaceuticals Inc(STU:T051)'s stock price today?
When is next earnings date of TRACON Pharmaceuticals Inc(STU:T051)?
Does TRACON Pharmaceuticals Inc(STU:T051) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |